Will Trump's tariffs affect Indian pharma?

As the international pharma market grows at a steady pace, Indian suppliers could be affected if US imposes tariffs on air cargo.

- 

The impact of the tariffs imposed by US President Donald Trump on air cargo from India is yet to be fully assessed. The government, it is reported, is awaiting the US response to the arms deal. US tariffs, the air cargo sector hopes, will not touch pharma exports.

Other than ecommerce – the mainstay of domestic cargo carriers – it is pharma that is helping the country’s air cargo sector record high tonnages. Not without reason since the international pharma market is not only growing but also holds potential — roughly three per cent of the air freight revenue of the aviation industry. As Shankar Iyer, Head of Cargo Africa, Middle East & India, Swiss WorldCargo, mentioned some time ago pharma shipments were of “significant importance to the entire air cargo industry – both from a strategic point of view and as a source of revenue”.